Cattle Respiratory Disease and Welfare

Bovine respiratory disease is the most costly and welfare-relevant disease in beef cattle, causing significant morbidity and mortality that responds to prevention through management and vaccination.

Key Facts

BRD accounts for over 70% of cattle morbidity and 40-50% of mortality in North American feedlots.
The disease complex involves multiple pathogens including Mannheimia haemolytica, Pasteurella multocida, and bovine respiratory viruses.
Weaning, transport, and mixing stress are major predisposing factors that compromise immune function at high-risk periods.
Metaphylaxis — treating all newly arrived cattle — reduces BRD incidence but carries antibiotic use concerns.
Early identification of BRD using behavioural observation improves treatment outcomes significantly compared to late detection.

Welfare Considerations

BRD causes significant acute suffering through fever, laboured breathing, and systemic illness. Chronically affected cattle that recover incompletely develop lung scarring that impairs welfare for the remainder of their production life. Prevention through vaccination, reducing stress at high-risk transitions, and prompt identification and treatment significantly reduces the scale of suffering. The widespread use of metaphylaxis for prevention raises antimicrobial stewardship concerns that must be balanced against individual animal welfare in treatment decisions.

What You Can Do

Support farms implementing systematic BRD prevention programmes including vaccination and low-stress handling at weaning.
Choose beef products from operations that publish health outcome data including BRD treatment rates.
Advocate for antibiotic stewardship policies that preserve treatment efficacy while meeting animal welfare requirements.
Support research into low-stress weaning and transport protocols that reduce BRD susceptibility at critical transition points.